Related Experiment Video
Updated: Jul 31, 2025

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
Canine hypoadrenocorticism: Insights into the Addisonian crisis.
Nolan V Chalifoux1, Hilary J Burgess1, Cindy X Feng1
1Department of Small Animal Clinical Sciences (Chalifoux, Kong, Snead) and Department of Veterinary Pathology (Burgess), Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4; School of Public Health, University of Saskatchewan, 104 Clinic Place, Saskatoon, Saskatchewan S7N 2Z4 (Feng).
Critically ill dogs with hypoadrenocorticism (Addison's disease) often present with collapse and depression. Identifying unique clinical signs can aid in early diagnosis of this critical condition.
Area of Science:
- Veterinary Medicine
- Internal Medicine
- Endocrinology
Background:
- Spontaneous hypoadrenocorticism, or Addison's disease, is a potentially life-threatening endocrine disorder in dogs.
- Dogs with critical hypoadrenocorticism present with unique clinical and clinicopathologic findings compared to those with a more stable presentation.
Purpose of the Study:
- To characterize the clinical presentation, physical examination findings, clinicopathologic data, and hospitalization duration in critically ill dogs with spontaneous hypoadrenocorticism.
- To compare these parameters between critically ill and stable dogs with hypoadrenocorticism.
- To evaluate the utility of the shock index and identify common stressors precipitating critical illness.
Main Methods:
- A retrospective study was conducted using medical records of 84 dogs diagnosed with spontaneous hypoadrenocorticism between 1998 and 2018.
- Data collected included presenting complaints, physical examination findings, clinicopathologic variables, and hospitalization time.
- Statistical analysis was performed to compare findings between critically ill and stable patient groups.
Main Results:
- Critically ill dogs were more likely to exhibit collapse and depression.
- Hyperlactatemia was infrequent in hypovolemic shock, and the shock index was not a reliable indicator in this subset.
- Isosthenuria, total hypocalcemia, and severe acidosis were significantly more common in critically ill dogs (P < 0.05).
- Owner separation was identified as the most frequent precipitating stressor.
Conclusions:
- Critically ill dogs with hypoadrenocorticism possess distinct clinical and clinicopathologic characteristics.
- These unique features may assist veterinarians in the early identification and management of critical Addison's disease in dogs.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hypothalamic-Pituitary Axis
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
Anatomy of the Adrenal Glands
These glands possess a distinctive yellow tinge due to the stored cholesterol and fatty acids required for hormone synthesis. They are encased in a fibrous capsule and cushioned by fat.
The adrenal gland comprises two distinct...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Acute Pancreatitis II: Clinical Manifestations and Management

